4.5 Article

P2X7 receptor antagonist protects retinal ganglion cells by inhibiting microglial activation in a rat chronic ocular hypertension model

期刊

MOLECULAR MEDICINE REPORTS
卷 17, 期 2, 页码 2289-2296

出版社

SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2017.8137

关键词

chronic ocular hypertension; microglial activation; retinal ganglion cells; 2 ',3 '-O-(4-benzoylbenzoyl)-ATP; Brilliant Blue G; P2X purinoceptor 7

资金

  1. Natural Science Foundation of Hubei Province [2014CFB213]
  2. Health and Birth Control Department of Hubei Province [81000380/H1204]
  3. Jingzhou Science and Technology funding [2014AC47B]

向作者/读者索取更多资源

Microglial activation and the release of pro-inflammatory cytokines occur during early glaucoma. However, the exact mechanism underlying the initiation of the microglial activation process remains unclear. Thus, the present study investigated the potential role of a purine receptor subtype, the P2X purinoceptor 7 (P2X7) receptor, during microglial activation in the retinal tissues of a rat chronic ocular hypertension (COH) model. This was achieved by cauterizing 3 of the 4 episcleral veins. Microglial activation and caspase-1 upregulation were observed in COH rat retinas by immunohistochemical and western blotting techniques. Intravitreal injection of 2,3-O-(4-benzoylbenzoyl)-ATP (BzATP), a P2X7 receptor agonist, induced microglial activation in normal rat retinal tissues, which was alleviated by pretreatment with the P2X7 receptor antagonist, Brilliant Blue G (BBG). BBG further attenuated caspase-1 increment in COH rat retinal tissues. The data demonstrated that BBG reduced TUNEL-positive retinal ganglion cells in whole-mount retinal tissues with COH and normal retinal tissues following intravitreal injection with BzATP. One may conclude that the P2X7 receptor may be involved in microglial activation in the COH retina and could be considered a target for neuronal protection in glaucoma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据